KalVista Pharmaceuticals (KALV) Return on Capital Employed (QoQ) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -1,976.00 |
| Oct 31, 2024 | -2,877.00 |
| Jul 31, 2024 | 1,285.00 |
| Apr 30, 2024 | 2,291.00 |
| Jan 31, 2024 | -2,621.00 |
| Oct 31, 2023 | -1,707.00 |
| Jul 31, 2023 | -991.00 |
| Apr 30, 2023 | -42.00 |
| Jan 31, 2023 | 378.00 |
| Oct 31, 2022 | -915.00 |
| Jul 31, 2022 | -878.00 |
| Apr 30, 2022 | -854.00 |
| Jan 31, 2022 | -850.00 |
| Oct 31, 2021 | -611.00 |
| Jul 31, 2021 | 1,187.00 |
| Apr 30, 2021 | 3,959.00 |
| Jan 31, 2021 | -622.00 |
| Oct 31, 2020 | -1,279.00 |
| Jul 31, 2020 | -1,191.00 |
| Apr 30, 2020 | -120.00 |
| Jan 31, 2020 | -897.00 |
| Oct 31, 2019 | -403.00 |
| Jul 31, 2019 | -222.00 |
| Apr 30, 2019 | -915.00 |
| Jan 31, 2019 | 647.00 |
| Oct 31, 2018 | 2,944.00 |
| Jul 31, 2018 | -952.00 |
| Apr 30, 2018 | 3,239.00 |
| Jan 31, 2018 | 585.00 |
| Oct 31, 2017 | -513.00 |
| Jul 31, 2017 | -1,160.00 |
| Mar 31, 2016 | -776.00 |
| Dec 31, 2015 | -695.00 |
| Sep 30, 2015 | 1,830.00 |
| Jun 30, 2015 | -38,293.00 |